Sifting through the surfeit of neuroinflammation tracers

The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) rev...

Full description

Saved in:
Bibliographic Details
Published inJournal of cerebral blood flow and metabolism Vol. 38; no. 2; pp. 204 - 224
Main Authors Cumming, Paul, Burgher, Bjorn, Patkar, Omkar, Breakspear, Michael, Vasdev, Neil, Thomas, Paul, Liu, Guo-Jun, Banati, Richard
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-(R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
AbstractList The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [ C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [ 11 C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-( R )-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [ 11 C]-( R )-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-(R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.
Author Patkar, Omkar
Banati, Richard
Vasdev, Neil
Thomas, Paul
Breakspear, Michael
Liu, Guo-Jun
Burgher, Bjorn
Cumming, Paul
AuthorAffiliation 1 School of Psychology and Counselling and IHBI, Faculty of Health, Queensland University of Technology, Brisbane, Australia
3 Metro North Mental Health Service, Brisbane, Australia
4 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA, USA
8 National Imaging Facility, Brain and Mind Centre and Faculty of Health Sciences, University of Sydney, Camperdown, Australia
5 Department of Radiology, Harvard Medical School, Boston, MA, USA
2 56362 QIMR Berghofer Institute , Brisbane, Australia
7 5419 Australian Nuclear Science and Technology Organisation , Lucas Heights, Australia
6 Herston Imaging Research Facility, Faculty of Medicine, 303224 University of Queensland Centre for Clinical Research , Herston, Australia
AuthorAffiliation_xml – name: 2 56362 QIMR Berghofer Institute , Brisbane, Australia
– name: 7 5419 Australian Nuclear Science and Technology Organisation , Lucas Heights, Australia
– name: 5 Department of Radiology, Harvard Medical School, Boston, MA, USA
– name: 4 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA, USA
– name: 6 Herston Imaging Research Facility, Faculty of Medicine, 303224 University of Queensland Centre for Clinical Research , Herston, Australia
– name: 8 National Imaging Facility, Brain and Mind Centre and Faculty of Health Sciences, University of Sydney, Camperdown, Australia
– name: 1 School of Psychology and Counselling and IHBI, Faculty of Health, Queensland University of Technology, Brisbane, Australia
– name: 3 Metro North Mental Health Service, Brisbane, Australia
Author_xml – sequence: 1
  givenname: Paul
  surname: Cumming
  fullname: Cumming, Paul
  email: paul.cumming@qut.edu.au
– sequence: 2
  givenname: Bjorn
  surname: Burgher
  fullname: Burgher, Bjorn
– sequence: 3
  givenname: Omkar
  surname: Patkar
  fullname: Patkar, Omkar
– sequence: 4
  givenname: Michael
  surname: Breakspear
  fullname: Breakspear, Michael
– sequence: 5
  givenname: Neil
  surname: Vasdev
  fullname: Vasdev, Neil
– sequence: 6
  givenname: Paul
  surname: Thomas
  fullname: Thomas, Paul
– sequence: 7
  givenname: Guo-Jun
  surname: Liu
  fullname: Liu, Guo-Jun
– sequence: 8
  givenname: Richard
  surname: Banati
  fullname: Banati, Richard
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29256293$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtLxDAQDqLornr3JD16qebRJM1FEPEFCx5U8BbSNNmNtIkmreC_N-u6ooKeZuB7Dd9MwaYP3gBwgOAxQpyfQMwR4_Vj3qua12wDTBClouQQsU0wWcLlEt8B05SeIIQ1oXQb7GCBKcOCTEB95-zg_LwYFjGM80WepkhjtMYNRbCFN2MMzttO9b0aXPDFEJU2Me2BLau6ZPY_5y54uLy4P78uZ7dXN-dns1JTCIdS26ahTctULYiuSCsqW1uNKkEpIy0TTdtAiC0hbUU4E1wZpAkzuG2FwMgIsgtOV77PY9ObVhufD-jkc3S9im8yKCd_It4t5Dy8Sioogphkg6NPgxheRpMG2bukTdcpb8KYJBK85gRTWGXq4fesr5B1XZnAVgQdQ0rRWKnd8FFLjnadRFAu_yJ__yUL4S_h2vsfSbmSJDU38imM0eee_-a_A0A2nOQ
CitedBy_id crossref_primary_10_1038_s41380_023_02188_8
crossref_primary_10_1186_s12974_023_02769_y
crossref_primary_10_1210_clinem_dgab797
crossref_primary_10_2967_jnumed_119_237735
crossref_primary_10_3390_molecules29245936
crossref_primary_10_1016_j_apsb_2020_08_006
crossref_primary_10_1177_0271678X21992457
crossref_primary_10_1186_s40658_021_00381_8
crossref_primary_10_1016_j_yexmp_2019_03_008
crossref_primary_10_1126_sciadv_adi8986
crossref_primary_10_1016_j_cpet_2018_12_010
crossref_primary_10_1016_j_neulet_2020_134938
crossref_primary_10_1161_STROKEAHA_122_036946
crossref_primary_10_1007_s11307_020_01575_9
crossref_primary_10_3390_cimb45110539
crossref_primary_10_1111_jnc_15615
crossref_primary_10_1002_mds_27620
crossref_primary_10_1007_s00259_019_04349_w
crossref_primary_10_1186_s13550_021_00786_7
crossref_primary_10_2214_AJR_21_26159
crossref_primary_10_1016_j_jneuroim_2024_578468
crossref_primary_10_1007_s00259_021_05495_w
crossref_primary_10_1186_s12974_018_1352_9
crossref_primary_10_62347_AICM8774
crossref_primary_10_1007_s00259_019_04294_8
crossref_primary_10_3390_ijms22115606
crossref_primary_10_1007_s00259_019_04403_7
crossref_primary_10_1016_j_biopsych_2018_02_1171
crossref_primary_10_1002_mds_28825
crossref_primary_10_1093_braincomms_fcac019
crossref_primary_10_1097_j_pain_0000000000003247
crossref_primary_10_3390_biom13020290
crossref_primary_10_1007_s00259_021_05425_w
crossref_primary_10_1007_s00259_020_04810_1
crossref_primary_10_1002_cmdc_201900608
crossref_primary_10_1007_s11307_021_01646_5
crossref_primary_10_1017_S0033291718003057
crossref_primary_10_1186_s12974_018_1347_6
crossref_primary_10_1177_0271678X20951995
crossref_primary_10_1016_j_bbi_2023_07_023
crossref_primary_10_1111_ejn_15613
crossref_primary_10_1111_epi_15967
crossref_primary_10_1038_s42003_022_04214_x
crossref_primary_10_1002_ddr_21547
crossref_primary_10_1038_s41380_020_0745_1
crossref_primary_10_1177_0271678X19858003
crossref_primary_10_1002_tcr_202300072
crossref_primary_10_3390_biomedicines10010034
crossref_primary_10_1093_brain_awy188
crossref_primary_10_1007_s00259_019_4268_4
crossref_primary_10_1186_s12974_020_02046_2
crossref_primary_10_3389_fimmu_2022_1010263
crossref_primary_10_1093_brain_awab127
crossref_primary_10_1177_0271678X241240843
crossref_primary_10_1007_s00247_021_05248_9
crossref_primary_10_1016_j_bmcl_2019_06_037
crossref_primary_10_1007_s00259_020_04885_w
crossref_primary_10_1007_s00259_021_05248_9
crossref_primary_10_1016_j_nbd_2022_105700
crossref_primary_10_1017_pen_2020_14
crossref_primary_10_1212_NXI_0000000000000984
crossref_primary_10_1097_RLU_0000000000004803
crossref_primary_10_1007_s00259_020_04844_5
crossref_primary_10_1016_j_cpet_2020_12_003
crossref_primary_10_1016_j_phrs_2023_106681
crossref_primary_10_1186_s12974_024_03080_0
crossref_primary_10_1016_j_pharmthera_2018_09_003
crossref_primary_10_23736_S1824_4785_22_03465_3
crossref_primary_10_1016_j_neuroimage_2020_117707
crossref_primary_10_1007_s00259_021_05398_w
crossref_primary_10_3389_fnmol_2022_981442
crossref_primary_10_1098_rsob_210173
crossref_primary_10_1177_1536012118792317
crossref_primary_10_1080_10253890_2022_2045269
crossref_primary_10_1016_j_drudis_2021_09_021
crossref_primary_10_1021_acs_jmedchem_1c00379
crossref_primary_10_1007_s00259_020_04732_y
crossref_primary_10_3389_fcell_2021_715444
crossref_primary_10_3390_cells12172128
crossref_primary_10_1016_j_tips_2019_11_005
crossref_primary_10_1021_acschemneuro_0c00802
crossref_primary_10_1111_epi_18351
crossref_primary_10_1016_j_bbr_2020_113004
crossref_primary_10_1016_j_expneurol_2024_114843
crossref_primary_10_3390_cells9020512
Cites_doi 10.1016/S0031-6997(24)01424-8
10.1210/en.2015-1795
10.1038/jcbfm.2012.59
10.1016/j.bmcl.2011.12.084
10.1126/science.1248725
10.1073/pnas.81.3.753
10.1073/pnas.1511003112
10.1038/jcbfm.2014.261
10.1126/science.1260590
10.1038/jcbfm.1993.6
10.1016/S0304-3835(00)00451-1
10.1080/13550280500187351
10.1023/A:1018567510105
10.1001/jamaneurol.2016.3764
10.1074/jbc.M114.578286
10.1177/0271678X16646788
10.1523/JNEUROSCI.1487-12.2012
10.1038/nri2550
10.1124/dmd.112.046342
10.1073/pnas.94.10.5101
10.1093/pcp/pch088
10.1016/j.pharmthera.2007.12.004
10.1016/j.bbi.2016.01.019
10.1093/brain/124.10.2014
10.1212/01.WNL.0000078192.95645.E6
10.1093/brain/123.11.2321
10.1016/S0026-895X(25)09743-3
10.1210/en.2013-1556
10.1016/S0014-2999(99)00118-1
10.2967/jnumed.117.195396
10.1007/s00259-012-2163-3
10.3389/fnagi.2017.00008
10.1074/jbc.M115.686360
10.1007/s00259-014-2955-8
10.1038/jcbfm.2011.147
10.2967/jnumed.116.178335
10.1176/appi.ajp.2016.15111417
10.1124/jpet.116.238568
10.1038/tp.2016.40
10.1016/S0021-9258(18)77217-7
10.1210/endo.139.12.6390
10.1016/0006-2952(96)00034-2
10.1007/s00259-015-3149-8
10.1016/0014-2999(81)90405-2
10.2967/jnumed.116.178996
10.2967/jnumed.110.077040
10.1016/j.bpj.2011.04.017
10.1016/S0960-894X(02)00886-7
10.1016/0024-3205(83)90062-0
10.1016/S0026-895X(25)10080-1
10.1073/pnas.74.9.3805
10.2967/jnumed.109.062265
10.1097/NEN.0b013e318188b204
10.1002/1097-0142(19900101)65:1<93::AID-CNCR2820650120>3.0.CO;2-1
10.1212/WNL.55.7.1052
10.1007/s00259-016-3444-z
10.1016/j.nucmedbio.2007.12.009
10.1001/jamaneurol.2015.0941
10.1023/A:1005933226966
10.1016/j.nucmedbio.2014.11.003
10.1038/sj.jcbfm.9600340
10.1016/S0378-4347(99)00439-9
10.1021/cn500138n
10.1016/j.neubiorev.2010.10.001
10.1016/S0928-4257(02)00018-9
10.1038/ncomms6452
10.1038/jcbfm.2014.55
10.1016/j.neuroimage.2009.11.056
10.1007/s10048-014-0409-x
10.1016/S1474-4422(15)70016-5
10.1093/ijnp/pyw077
10.1007/s00259-007-0645-5
10.1177/0271678X17699223
10.1080/15384101.2017.1281477
10.1016/S0021-9258(18)92812-7
10.1016/0024-3205(93)90293-C
10.1001/jamapsychiatry.2014.2427
10.1002/jlcr.1752
10.1016/S0140-6736(01)05625-2
10.1016/j.neuroimage.2004.09.034
10.1111/bpa.12196
10.1002/syn.20027
10.1007/s00259-011-1784-2
10.1089/dna.2016.3385
10.1007/s00259-016-3517-z
10.1007/s00259-017-3799-9
10.2967/jnumed.114.143727
10.1034/j.1600-0404.2001.103005309.x
10.1038/jcbfm.2014.46
10.1007/s004410051166
10.1111/bpa.12192
10.1176/appi.ajp.2016.15111417r
10.2967/jnumed.116.183202
10.1038/jcbfm.2010.63
10.1016/j.bbi.2013.06.010
10.1111/j.1460-9568.2006.04975.x
10.2967/jnumed.115.156083
10.1111/j.1471-4159.2007.04690.x
10.1038/sj.jcbfm.9600325
10.2967/jnumed.110.079459
10.2967/jnumed.107.044842
10.1002/ana.410260611
10.1016/0361-9230(87)90158-4
10.1006/excr.1998.4084
10.2967/jnumed.113.121020
10.1111/bpa.12195
10.1073/pnas.86.24.9813
10.1038/jcbfm.2012.46
10.1007/s10495-010-0460-5
10.1007/s00259-013-2359-1
10.1111/j.1471-4159.1989.tb07361.x
10.1038/jcbfm.2014.63
10.1038/mp.2016.248
10.1111/ejn.12946
10.1097/00001756-200111160-00012
10.1038/mp.2016.180
10.2967/jnumed.114.149443
10.1002/syn.20257
10.1111/jnc.13370
10.1177/0271678X17710182
10.1038/jcbfm.2012.131
10.1073/pnas.86.13.4897
10.1002/syn.20394
10.1016/S0969-8051(02)00410-9
10.1016/j.neuroimage.2007.11.011
10.1038/sj.jcbfm.9600092
10.1046/j.1471-4159.2000.0741694.x
10.1186/s13550-017-0304-1
10.1126/science.aaa1534
10.1038/jcbfm.2011.55
10.1016/j.tips.2006.06.005
10.1021/acs.jmedchem.5b00932
10.1111/bpa.12198
10.1016/j.bbadis.2015.11.011
10.1016/S0021-9258(19)47078-6
10.1038/jcbfm.2014.202
10.2967/jnumed.108.060186
10.1007/s00259-005-0052-8
10.1016/S0039-128X(96)00154-7
10.1002/syn.21970
10.1186/2191-219X-2-15
10.1371/journal.pone.0167307
10.1016/j.redox.2016.08.002
10.1212/WNL.53.9.2199
10.5694/j.1326-5377.2009.tb02371.x
10.1016/j.neuroimage.2006.11.003
10.1074/jbc.M114.549634
10.2967/jnumed.115.169078
10.1016/j.nucmedbio.2010.07.008
ContentType Journal Article
Copyright The Author(s) 2017
The Author(s) 2017 2017 International Society for Cerebral Blood Flow and Metabolism
Copyright_xml – notice: The Author(s) 2017
– notice: The Author(s) 2017 2017 International Society for Cerebral Blood Flow and Metabolism
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1177/0271678X17748786
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1559-7016
EndPage 224
ExternalDocumentID PMC5951023
29256293
10_1177_0271678X17748786
10.1177_0271678X17748786
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
-Q-
-TM
.55
.GJ
0R~
29K
2WC
36B
39C
3O-
4.4
53G
54M
5GY
5RE
5VS
70F
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AABMB
AACKU
AACMV
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJPV
AAKGS
AANSI
AAPEO
AAQGT
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAVDI
AAXOT
AAYTG
AAZBJ
ABAWP
ABAWZ
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHKI
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQNX
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEIA
ADMPF
ADNON
ADRRZ
ADTBJ
ADUKL
ADVBO
ADZZY
AECGH
AENEX
AEPTA
AEQLS
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFFZS
AFKRA
AFKRG
AFMOU
AFOSN
AFQAA
AFUIA
AFVCE
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AHDMH
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
AUTPY
AYAKG
B8M
BAWUL
BBNVY
BBRGL
BDDNI
BENPR
BHPHI
BKIIM
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
C45
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DIK
DOPDO
DV7
E3Z
EBS
EE.
EJD
EMOBN
F5P
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HCIFZ
HMCUK
HYE
HZ~
J8X
JSO
K.F
KQ8
LK8
M1P
M7P
O9-
OK1
OVD
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
RNS
RNTTT
ROL
RPM
SASJQ
SAUOL
SCNPE
SFC
SHG
SPQ
SPV
TEORI
TR2
UKHRP
W2D
X7M
YFH
YOC
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
AAYXX
AJGYC
CITATION
AAEJI
AAPII
AJVBE
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7X8
5PM
AJHME
ID FETCH-LOGICAL-c500t-cfbb5bd6a893c43d94f8fc1495563d69bdb002f33d437697ae1c36e2dd9921e93
ISSN 0271-678X
1559-7016
IngestDate Thu Aug 21 18:21:54 EDT 2025
Tue Aug 05 10:52:44 EDT 2025
Mon Jul 21 05:58:19 EDT 2025
Thu Jul 03 08:34:01 EDT 2025
Thu Apr 24 23:03:35 EDT 2025
Tue Jun 17 22:29:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords positron emission tomography
neuroinflammation
microglia
Translocator protein
quantitation
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c500t-cfbb5bd6a893c43d94f8fc1495563d69bdb002f33d437697ae1c36e2dd9921e93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.1177/0271678X17748786
PMID 29256293
PQID 1978732504
PQPubID 23479
PageCount 21
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5951023
proquest_miscellaneous_1978732504
pubmed_primary_29256293
crossref_citationtrail_10_1177_0271678X17748786
crossref_primary_10_1177_0271678X17748786
sage_journals_10_1177_0271678X17748786
PublicationCentury 2000
PublicationDate 2018-02-01
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: United States
– name: Sage UK: London, England
PublicationTitle Journal of cerebral blood flow and metabolism
PublicationTitleAlternate J Cereb Blood Flow Metab
PublicationYear 2018
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Gerhard, Banati, Goerres 2003; 61
Braestrup, Squires 1977; 74
Woods, Zisterer, Williams 1996; 51
Gerhard, Schwarz, Myers 2005; 24
Kuhlmann, Guilarte 2000; 74
Owen, Howell, Tang 2010; 30
Le Fur, Perrier, Vaucher 1983; 32
Heneka, Carson, El Khoury 2015; 14
Narendran, Frankle 2016; 173
Papadopoulos, Baraldi, Guilarte 2006; 27
Graeber 2014; 24
Tu, Morohaku, Manna 2014; 289
Iversen, Hansen, Bender 2006; 33
Sileikyte, Blachly-Dyson, Sewell 2014; 289
Kreisl, Fujita, Fujimura 2010; 49
Eberl, Katsifis, Peyronneau 2017; 44
Rizzo, Veronese, Tonietto 2014; 34
Snyder, Van Antwerpen 1998; 294
Estes, McAllister 2014; 24
Gavish, Bachman, Shoukrun 1999; 51
Fan, Harold, Pasqualetti 2015; 56
Rusjan, Wilson, Bloomfield 2011; 31
Matheson, Plaven-Sigray, Forsberg 2017; 7
Brendel, Kleinberger, Probst 2017; 9
Goverman 2009; 9
Fujita, Imaizumi, Zoghbi 2008; 40
Zanotti-Fregonara, Zhang, Jenko 2014; 5
Collste, Forsberg, Varrone 2016; 43
Middleton, Kam, Liu 2017; 36
Hirsch, Decaudin, Susin 1998; 241
Lindemann, Koch, Degenhardt 2004; 45
Zeno, Veenman, Katz 2012; 12
Endres, Pomper, James 2009; 50
Gershen, Zanotti-Fregonara, Dustin 2015; 72
Frankle, Narendran, Wood 2017; 71
Veenman, Gavish 2012; 12
Golla, Boellaard, Oikonen 2015; 35
Yoder, Territo, Hutchins 2015; 42
Holmes, Hinz, Drake 2016; 21
Casteels, Koole, Celen 2012; 39
Sandiego, Gallezot, Pittman 2015; 112
Cagnin, Brooks, Kennedy 2001; 358
Li, Liu, Zheng 2015; 347
Zhang, Maeda, Furutsuka 2003; 13
Miyazawa, Hamel, Diksic 1998; 38
Chen, Guilarte 2008; 118
Chaki, Funakoshi, Yoshikawa 1999; 371
Feng, Svarer, Thomsen 2014; 55
Canat, Carayon, Bouaboula 1993; 52
Tu, Zhao, Hussein 2016; 157
Banati, Myers, Kreutzberg 1997; 26
Hardwick, Fertikh, Culty 1999; 59
Fan, Calsolaro, Atkinson 2016; 57
Wadsworth, Jones, Chau 2012; 22
Mukhin, Papadopoulos, Costa 1989; 86
Turkheimer, Edison, Pavese 2007; 48
Fujimura, Zoghbi, Simeon 2009; 50
Papadopoulos, Amri, Boujrad 1997; 62
Parola, Stump, Pepperl 1991; 266
Wilson, Garcia, Parkes 2008; 35
Filiou, Arefin, Moscato 2014; 15
De Vos, Dumont, Santens 1999; 736
Jucaite, Cselenyi, Arvidsson 2012; 2
Hannestad, DellaGioia, Gallezot 2013; 33
Kreisl, Jenko, Hines 2013; 33
Mattner, Bandin, Staykova 2011; 38
Cagnin, Myers, Gunn 2001; 124
Peyronneau, Saba, Goutal 2013; 41
Venneti, Wang, Nguyen 2008; 67
Banati, Middleton, Chan 2014; 5
Bloomfield, Howes, Turkheimer 2016; 173
Cumming, Pedersen, Minuzzi 2006; 59
Owen, Guo, Kalk 2014; 34
Svahn, Becker, Graeber 2014; 24
Veenman, Alten, Linnemannstons 2010; 15
Maschauer, Haller, Riss 2015; 135
Mitsui, Morimoto, Niwa 2017; 360
Venneti, Lopresti, Wang 2007; 102
Hirsch, Beyer, Malkowitz 1989; 35
Carson, Channing, Blasberg 1993; 13
Katsifis, Loc'h, Henderson 2011; 38
Betlazar, Middleton, Banati 2016; 9
Brown, Fujita, Fujimura 2007; 48
Besman, Yanagibashi, Lee 1989; 86
Antkiewicz-Michaluk, Guidotti, Krueger 1988; 34
Imaizumi, Briard, Zoghbi 2007; 61
Banati, Goerres, Myers 1999; 53
Jaremko, Jaremko, Giller 2014; 343
Alho, Varga, Krueger 1994; 5
Wang, Morgan, Spector 1984; 81
Kanegawa, Collste, Forsberg 2016; 54
Hammoud, Endres, Chander 2005; 11
Mattner, Mardon, Katsifis 2008; 35
Cumming, Maschauer, Riss 2014; 34
Morohaku, Pelton, Daugherty 2014; 155
Brown, Degenhardt, Kotoula 2000; 156
Wang, Zhai, Xue 2016; 11
Banati, Hickie 2009; 190
Luus, Hanani, Reynolds 2010; 53
Setiawan, Wilson, Mizrahi 2015; 72
Ikawa, Lohith, Shrestha 2017; 58
Guo, Colasanti, Owen 2013; 54
Owen, Narayan, Wells 2017; 37
Owen, Gunn, Rabiner 2011; 52
Fan, Lindemann, Feuilloley 2012; 12
Salinas, Searle, Gunn 2015; 35
Pinborg, Videbaek, Ziebell 2007; 34
Ikoma, Yasuno, Ito 2007; 27
Kropholler, Boellaard, Schuitemaker 2005; 25
Krueger, Papadopoulos 1990; 265
Varrone, Oikonen, Forsberg 2015; 42
Coughlin, Wang, Ambinder 2016; 6
Feeney, Scott, Raffel 2016; 43
Guo, Kalathur, Liu 2015; 347
Celen, Koole, De Angelis 2010; 51
Pedersen, Minuzzi, Wirenfeldt 2006; 24
Banati, Cagnin, Brooks 2001; 12
Cumming, Danielsen, Vafaee 2001; 103
Yeliseev, Krueger, Kaplan 1997; 94
Mizrahi, Rusjan, Kennedy 2012; 32
Maeda, Suhara, Zhang 2004; 52
Feng, Jensen, Thomsen 2017; 58
Zhao, Tu, Mukai 2016; 291
Lockhart, Davis, Matthews 2003; 30
Pandey, Flockerzi, Hauser 2011; 100
Lavisse, Guillermier, Herard 2012; 32
Coughlin, Wang, Minn 2017; 74
Black, Ikezaki, Santori 1990; 65
Pappata, Levasseur, Gunn 2000; 55
Liu, Middleton, Hatty 2014; 24
Sprengel, Werner, Seeburg 1989; 264
Schoemaker, Bliss, Yamamura 1981; 71
Basile, Weissman, Skolnick 1987; 19
Damont, Medran-Navarrete, Cacheux 2015; 58
Yaqub, van Berckel, Schuitemaker 2012; 32
Liu, Middleton, Kam 2017; 16
Eshleman, Murray 1989; 53
Yokokura, Terada, Bunai 2017; 37
Berk, Kapczinski, Andreazza 2011; 35
Lavisse, Garcia-Lorenzo, Peyronneau 2015; 56
Saba, Goutal, Kuhnast 2015; 42
Li, Papadopoulos 1998; 139
Banati 2002; 96
Junck, Olson, Ciliax 1989; 26
Asselin, Montgomery, Grasby 2007; 27
Owen, Yeo, Gunn 2012; 32
Inta, Lang, Borgwardt 2017; 43
Banati, Newcombe, Gunn 2000; 123
Janssen, Vugts, Funke 2016; 1862
Varrone, Mattsson, Forsberg 2013; 40
bibr76-0271678X17748786
bibr109-0271678X17748786
Sprengel R (bibr49-0271678X17748786) 1989; 264
bibr17-0271678X17748786
bibr33-0271678X17748786
bibr117-0271678X17748786
bibr133-0271678X17748786
bibr41-0271678X17748786
bibr84-0271678X17748786
bibr4-0271678X17748786
Antkiewicz-Michaluk L (bibr56-0271678X17748786) 1988; 34
bibr2-0271678X17748786
bibr100-0271678X17748786
bibr143-0271678X17748786
bibr94-0271678X17748786
bibr125-0271678X17748786
bibr151-0271678X17748786
bibr25-0271678X17748786
bibr68-0271678X17748786
bibr123-0271678X17748786
bibr115-0271678X17748786
bibr131-0271678X17748786
bibr102-0271678X17748786
bibr31-0271678X17748786
bibr15-0271678X17748786
bibr86-0271678X17748786
bibr78-0271678X17748786
bibr107-0271678X17748786
bibr99-0271678X17748786
bibr88-0271678X17748786
bibr141-0271678X17748786
bibr105-0271678X17748786
bibr23-0271678X17748786
bibr96-0271678X17748786
bibr110-0271678X17748786
bibr10-0271678X17748786
Krueger KE (bibr40-0271678X17748786) 1990; 265
bibr104-0271678X17748786
bibr155-0271678X17748786
bibr8-0271678X17748786
Parola AL (bibr48-0271678X17748786) 1991; 266
bibr147-0271678X17748786
bibr113-0271678X17748786
bibr120-0271678X17748786
bibr11-0271678X17748786
bibr80-0271678X17748786
bibr139-0271678X17748786
bibr7-0271678X17748786
bibr37-0271678X17748786
bibr64-0271678X17748786
bibr72-0271678X17748786
bibr146-0271678X17748786
bibr138-0271678X17748786
bibr98-0271678X17748786
bibr121-0271678X17748786
bibr29-0271678X17748786
bibr81-0271678X17748786
bibr112-0271678X17748786
bibr14-0271678X17748786
bibr87-0271678X17748786
bibr61-0271678X17748786
bibr22-0271678X17748786
Alho H (bibr77-0271678X17748786) 1994; 5
bibr95-0271678X17748786
bibr124-0271678X17748786
bibr135-0271678X17748786
bibr45-0271678X17748786
bibr92-0271678X17748786
bibr101-0271678X17748786
bibr119-0271678X17748786
bibr132-0271678X17748786
bibr79-0271678X17748786
bibr140-0271678X17748786
bibr127-0271678X17748786
bibr1-0271678X17748786
bibr53-0271678X17748786
bibr142-0271678X17748786
bibr134-0271678X17748786
bibr126-0271678X17748786
bibr24-0271678X17748786
bibr150-0271678X17748786
bibr50-0271678X17748786
bibr93-0271678X17748786
bibr26-0271678X17748786
bibr67-0271678X17748786
bibr69-0271678X17748786
bibr116-0271678X17748786
Luus C (bibr90-0271678X17748786) 2010; 53
bibr16-0271678X17748786
bibr59-0271678X17748786
bibr34-0271678X17748786
bibr42-0271678X17748786
bibr85-0271678X17748786
bibr108-0271678X17748786
bibr3-0271678X17748786
bibr44-0271678X17748786
bibr128-0271678X17748786
bibr136-0271678X17748786
bibr57-0271678X17748786
Inta D (bibr30-0271678X17748786) 2017; 43
bibr149-0271678X17748786
bibr60-0271678X17748786
bibr144-0271678X17748786
bibr28-0271678X17748786
bibr73-0271678X17748786
bibr91-0271678X17748786
bibr52-0271678X17748786
bibr152-0271678X17748786
bibr70-0271678X17748786
bibr154-0271678X17748786
bibr83-0271678X17748786
Gavish M (bibr46-0271678X17748786) 1999; 51
bibr18-0271678X17748786
bibr118-0271678X17748786
bibr5-0271678X17748786
Wang H (bibr62-0271678X17748786) 2016; 11
bibr157-0271678X17748786
bibr36-0271678X17748786
bibr38-0271678X17748786
Hirsch JD (bibr43-0271678X17748786) 1989; 35
bibr71-0271678X17748786
bibr20-0271678X17748786
bibr63-0271678X17748786
bibr89-0271678X17748786
bibr54-0271678X17748786
bibr97-0271678X17748786
Turkheimer FE (bibr103-0271678X17748786) 2007; 48
bibr156-0271678X17748786
bibr39-0271678X17748786
bibr13-0271678X17748786
bibr129-0271678X17748786
bibr130-0271678X17748786
bibr47-0271678X17748786
bibr21-0271678X17748786
bibr12-0271678X17748786
bibr55-0271678X17748786
bibr82-0271678X17748786
Zeno S (bibr66-0271678X17748786) 2012; 12
bibr19-0271678X17748786
Veenman L (bibr65-0271678X17748786) 2012; 12
bibr74-0271678X17748786
bibr145-0271678X17748786
bibr35-0271678X17748786
bibr6-0271678X17748786
bibr122-0271678X17748786
bibr137-0271678X17748786
Hardwick M (bibr75-0271678X17748786) 1999; 59
bibr32-0271678X17748786
Fan J (bibr51-0271678X17748786) 2012; 12
bibr111-0271678X17748786
bibr148-0271678X17748786
bibr9-0271678X17748786
bibr58-0271678X17748786
bibr106-0271678X17748786
bibr114-0271678X17748786
bibr153-0271678X17748786
bibr27-0271678X17748786
References_xml – volume: 9
  start-page: 8
  year: 2017
  article-title: Increase of TREM2 during aging of an Alzheimer's disease mouse model is paralleled by microglial activation and amyloidosis
  publication-title: Front Aging Neurosci
– volume: 24
  start-page: 991
  year: 2006
  end-page: 1000
  article-title: Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain
  publication-title: Eur J Neurosci
– volume: 53
  start-page: 501
  year: 2010
  end-page: 510
  article-title: The development of PET radioligands for imaging the translocator protein (18 kDa): what have we learned?
  publication-title: J Labelled Compd Radiopharm
– volume: 12
  start-page: 369
  year: 2012
  end-page: 386
  article-title: Structural and functional evolution of the translocator protein (18 kDa)
  publication-title: Curr Mol Med
– volume: 56
  start-page: 1048
  year: 2015
  end-page: 1054
  article-title: Optimized quantification of translocator protein radioligand (1)(8)F-DPA-714 uptake in the brain of genotyped healthy volunteers
  publication-title: J Nucl Med
– volume: 190
  start-page: S26
  year: 2009
  end-page: S32
  article-title: Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders
  publication-title: Med J Aust
– volume: 156
  start-page: 125
  year: 2000
  end-page: 132
  article-title: Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis
  publication-title: Cancer Lett
– volume: 32
  start-page: 1600
  year: 2012
  end-page: 1608
  article-title: Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies
  publication-title: J Cereb Blood Flow Metab
– volume: 42
  start-page: 1738
  year: 2015
  end-page: 1745
  article-title: Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation
  publication-title: Eur J Neurosci
– volume: 33
  start-page: 810
  year: 2006
  end-page: 816
  article-title: Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 14
  start-page: 388
  year: 2015
  end-page: 405
  article-title: Neuroinflammation in Alzheimer's disease
  publication-title: Lancet Neurol
– volume: 34
  start-page: 1060
  year: 2014
  end-page: 1069
  article-title: Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data
  publication-title: J Cereb Blood Flow Metab
– volume: 33
  start-page: 53
  year: 2013
  end-page: 58
  article-title: A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation
  publication-title: J Cereb Blood Flow Metab
– volume: 32
  start-page: 10809
  year: 2012
  end-page: 10818
  article-title: Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging
  publication-title: J Neurosci
– volume: 5
  start-page: 5452
  year: 2014
  article-title: Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
  publication-title: Nat Commun
– volume: 35
  start-page: 804
  year: 2011
  end-page: 817
  article-title: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors
  publication-title: Neurosci Biobehav Rev
– volume: 38
  start-page: 137
  year: 2011
  end-page: 148
  article-title: A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma
  publication-title: Nucl Med Biol
– volume: 56
  start-page: 707
  year: 2015
  end-page: 713
  article-title: Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort?
  publication-title: J Nucl Med
– volume: 9
  start-page: 144
  year: 2016
  end-page: 156
  article-title: The impact of high and low dose ionising radiation on the central nervous system
  publication-title: Redox Biol
– volume: 81
  start-page: 753
  year: 1984
  end-page: 756
  article-title: Benzodiazepines that bind at peripheral sites inhibit cell proliferation
  publication-title: Proc Natl Acad Sci USA
– volume: 32
  start-page: 968
  year: 2012
  end-page: 972
  article-title: Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA
  publication-title: J Cereb Blood Flow Metab
– volume: 54
  start-page: 1915
  year: 2013
  end-page: 1923
  article-title: Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding
  publication-title: J Nucl Med
– volume: 41
  start-page: 122
  year: 2013
  end-page: 131
  article-title: Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand
  publication-title: Drug Metab Dispos Biol Fate Chem
– volume: 27
  start-page: 378
  year: 2007
  end-page: 392
  article-title: Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region
  publication-title: J Cereb Blood Flow Metab
– volume: 74
  start-page: 67
  year: 2017
  end-page: 74
  article-title: Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players
  publication-title: JAMA Neurol
– volume: 58
  start-page: 7449
  year: 2015
  end-page: 7464
  article-title: Novel pyrazolo[1,5-a]pyrimidines as translocator protein 18 kDa (TSPO) ligands: synthesis, in vitro biological evaluation, [(18)F]-labeling, and in vivo neuroinflammation PET images
  publication-title: J Med Chem
– volume: 15
  start-page: 201
  year: 2014
  end-page: 212
  article-title: ‘Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared
  publication-title: Neurogenetics
– volume: 32
  start-page: 1839
  year: 1983
  end-page: 1847
  article-title: Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)- -methyl- -(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies
  publication-title: Life Sci
– volume: 135
  start-page: 908
  year: 2015
  end-page: 917
  article-title: Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain
  publication-title: J Neurochem
– volume: 52
  start-page: 283
  year: 2004
  end-page: 291
  article-title: Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain
  publication-title: Synapse
– volume: 358
  start-page: 461
  year: 2001
  end-page: 467
  article-title: In-vivo measurement of activated microglia in dementia
  publication-title: Lancet
– volume: 34
  start-page: 1450
  year: 2007
  end-page: 1453
  article-title: [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region
  publication-title: Neuroimage
– volume: 72
  start-page: 268
  year: 2015
  end-page: 275
  article-title: Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes
  publication-title: JAMA Psychiatry
– volume: 2
  start-page: 15
  year: 2012
  article-title: Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain – a PET study in control subjects
  publication-title: EJNMMI Res
– volume: 96
  start-page: 289
  year: 2002
  end-page: 299
  article-title: Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?
  publication-title: J Physiol Paris
– volume: 48
  start-page: 2072
  year: 2007
  end-page: 2079
  article-title: Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation
  publication-title: J Nucl Med
– volume: 347
  start-page: 551
  year: 2015
  end-page: 555
  article-title: Protein structure. Structure and activity of tryptophan-rich TSPO proteins
  publication-title: Science
– volume: 50
  start-page: 1047
  year: 2009
  end-page: 1053
  article-title: Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06
  publication-title: J Nucl Med
– volume: 51
  start-page: 629
  year: 1999
  end-page: 650
  article-title: Enigma of the peripheral benzodiazepine receptor
  publication-title: Pharmacol Rev
– volume: 38
  start-page: 19
  year: 1998
  end-page: 26
  article-title: Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods
  publication-title: J Neurooncol
– volume: 155
  start-page: 89
  year: 2014
  end-page: 97
  article-title: Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis
  publication-title: Endocrinology
– volume: 42
  start-page: 305
  year: 2015
  end-page: 308
  article-title: Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake
  publication-title: Nucl Med Biol
– volume: 55
  start-page: 1052
  year: 2000
  end-page: 1054
  article-title: Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195
  publication-title: Neurology
– volume: 53
  start-page: 494
  year: 1989
  end-page: 502
  article-title: Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes
  publication-title: J Neurochem
– volume: 35
  start-page: 766
  year: 2015
  end-page: 772
  article-title: Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients
  publication-title: J Cereb Blood Flow Metab
– volume: 1862
  start-page: 425
  year: 2016
  end-page: 441
  article-title: Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: recent developments in positron emission tomography
  publication-title: Biochim Biophys Acta
– volume: 48
  start-page: 158
  year: 2007
  end-page: 167
  article-title: Reference and target region modeling of [11C]-(R)-PK11195 brain studies
  publication-title: J Nucl Med
– volume: 265
  start-page: 15015
  year: 1990
  end-page: 15022
  article-title: Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells
  publication-title: J Biol Chem
– volume: 37
  start-page: 877
  year: 2017
  end-page: 889
  article-title: Depiction of microglial activation in aging and dementia: positron emission tomography with [11C]DPA713 versus [11C](R)PK11195
  publication-title: J Cereb Blood Flow Metab
– volume: 52
  start-page: 24
  year: 2011
  end-page: 32
  article-title: Mixed-affinity binding in humans with 18-kDa translocator protein ligands
  publication-title: J Nucl Med
– volume: 24
  start-page: 631
  year: 2014
  end-page: 653
  article-title: The 18 kDa translocator protein, microglia and neuroinflammation
  publication-title: Brain Pathol
– volume: 343
  start-page: 1363
  year: 2014
  end-page: 1366
  article-title: Structure of the mitochondrial translocator protein in complex with a diagnostic ligand
  publication-title: Science
– volume: 30
  start-page: 199
  year: 2003
  end-page: 206
  article-title: The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker
  publication-title: Nucl Med Biol
– volume: 21
  start-page: 1672
  year: 2016
  end-page: 1679
  article-title: In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study
  publication-title: Mol Psychiatry
– volume: 61
  start-page: 686
  year: 2003
  end-page: 689
  article-title: [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy
  publication-title: Neurology
– volume: 13
  start-page: 24
  year: 1993
  end-page: 42
  article-title: Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography
  publication-title: J Cereb Blood Flow Metab
– volume: 103
  start-page: 309
  year: 2001
  end-page: 315
  article-title: Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts
  publication-title: Acta Neurol Scand
– volume: 289
  start-page: 27444
  year: 2014
  end-page: 27454
  article-title: Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis
  publication-title: J Biol Chem
– volume: 266
  start-page: 14082
  year: 1991
  end-page: 14087
  article-title: Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein
  publication-title: J Biol Chem
– volume: 347
  start-page: 555
  year: 2015
  end-page: 558
  article-title: Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism
  publication-title: Science
– volume: 58
  start-page: 989
  year: 2017
  end-page: 995
  article-title: The variability of translocator protein signal in brain and blood of genotyped healthy humans using in vivo 123I-CLINDE SPECT imaging: a test-retest study
  publication-title: J Nucl Med
– volume: 67
  start-page: 1001
  year: 2008
  end-page: 1010
  article-title: The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders
  publication-title: J Neuropathol Exp Neurol
– volume: 40
  start-page: 43
  year: 2008
  end-page: 52
  article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation
  publication-title: Neuroimage
– volume: 360
  start-page: 457
  year: 2017
  end-page: 465
  article-title: Quantification of ONO-2952 occupancy of 18-kDa translocator protein in conscious monkey brains using positron emission tomography
  publication-title: J Pharmacol Exp Ther
– volume: 57
  start-page: 1753
  year: 2016
  end-page: 1759
  article-title: Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein
  publication-title: J Nucl Med
– volume: 112
  start-page: 12468
  year: 2015
  end-page: 12473
  article-title: Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
  publication-title: Proc Natl Acad Sci U S A
– volume: 34
  start-page: 1148
  year: 2014
  end-page: 1156
  article-title: Radiosynthesis and validation of (1)(8)F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain
  publication-title: J Cereb Blood Flow Metab
– volume: 71
  start-page: e21970
  issue: 7
  year: 2017
  article-title: Brain translocator protein occupancy by ONO-2952 in healthy adults: a phase 1 PET study using [11 C]PBR28
  publication-title: Synapse
– volume: 35
  start-page: 305
  year: 2008
  end-page: 314
  article-title: Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors
  publication-title: Nucl Med Biol
– volume: 51
  start-page: 1584
  year: 2010
  end-page: 1591
  article-title: Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain
  publication-title: J Nucl Med
– volume: 59
  start-page: 418
  year: 2006
  end-page: 426
  article-title: Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography
  publication-title: Synapse
– volume: 36
  start-page: 103
  year: 2017
  end-page: 108
  article-title: Epigenetic silencing of the human 18 kDa translocator protein in a T cell leukemia cell line
  publication-title: DNA Cell Biol
– volume: 157
  start-page: 1110
  year: 2016
  end-page: 1121
  article-title: Translocator protein (TSPO) affects mitochondrial fatty acid oxidation in steroidogenic cells
  publication-title: Endocrinology
– volume: 72
  start-page: 882
  year: 2015
  end-page: 888
  article-title: Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein
  publication-title: JAMA Neurol
– volume: 35
  start-page: 779
  year: 2008
  end-page: 789
  article-title: Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS)
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 54
  start-page: 149
  year: 2016
  end-page: 157
  article-title: In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects
  publication-title: Brain Behav Immun
– volume: 34
  start-page: 989
  year: 2014
  end-page: 994
  article-title: Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study
  publication-title: J Cereb Blood Flow Metab
– volume: 291
  start-page: 1591
  year: 2016
  end-page: 1603
  article-title: Mitochondrial translocator protein (TSPO) function is not essential for heme biosynthesis
  publication-title: J Biol Chem
– volume: 27
  start-page: 173
  year: 2007
  end-page: 184
  article-title: Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106
  publication-title: J Cereb Blood Flow Metab
– volume: 173
  start-page: 537
  year: 2016
  end-page: 538
  article-title: Response to Narendran and Frankle: The interpretation of PET microglial imaging in schizophrenia
  publication-title: Am J Psychiatry
– volume: 7
  start-page: 58
  year: 2017
  article-title: Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data
  publication-title: EJNMMI Res
– volume: 12
  start-page: 398
  year: 2012
  end-page: 412
  article-title: The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression
  publication-title: Curr Mol Med
– volume: 12
  start-page: 3439
  year: 2001
  end-page: 3442
  article-title: Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury
  publication-title: Neuroreport
– volume: 86
  start-page: 9813
  year: 1989
  end-page: 9816
  article-title: Mitochondrial benzodiazepine receptors regulate steroid biosynthesis
  publication-title: Proc Natl Acad Sci USA
– volume: 34
  start-page: 272
  year: 1988
  end-page: 278
  article-title: Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands
  publication-title: Mol Pharmacol
– volume: 13
  start-page: 201
  year: 2003
  end-page: 204
  article-title: [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR)
  publication-title: Bioorg Med Chem Lett
– volume: 27
  start-page: 402
  year: 2006
  end-page: 409
  article-title: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function
  publication-title: Trends Pharmacol Sci
– volume: 52
  start-page: 107
  year: 1993
  end-page: 118
  article-title: Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells
  publication-title: Life Sci
– volume: 26
  start-page: 77
  year: 1997
  end-page: 82
  article-title: PK (‘peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia
  publication-title: J Neurocytol
– volume: 74
  start-page: 1694
  year: 2000
  end-page: 1704
  article-title: Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity
  publication-title: J Neurochem
– volume: 124
  start-page: 2014
  year: 2001
  end-page: 2027
  article-title: In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
  publication-title: Brain
– volume: 26
  start-page: 752
  year: 1989
  end-page: 758
  article-title: PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site
  publication-title: Ann Neurol
– volume: 19
  start-page: 1
  year: 1987
  end-page: 7
  article-title: Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex
  publication-title: Brain Res Bull
– volume: 45
  start-page: 723
  year: 2004
  end-page: 733
  article-title: A novel Arabidopsis thaliana protein is a functional peripheral-type benzodiazepine receptor
  publication-title: Plant Cell Physiol
– volume: 12
  start-page: 494
  year: 2012
  end-page: 501
  article-title: The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS)
  publication-title: Curr Mol Med
– volume: 61
  start-page: 595
  year: 2007
  end-page: 605
  article-title: Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain
  publication-title: Synapse
– volume: 35
  start-page: 304
  year: 2015
  end-page: 311
  article-title: The simplified reference tissue model: model assumption violations and their impact on binding potential
  publication-title: J Cereb Blood Flow Metab
– volume: 24
  start-page: 665
  year: 2014
  end-page: 670
  article-title: Emergent properties of microglia
  publication-title: Brain Pathol
– volume: 38
  start-page: 1516
  year: 2011
  end-page: 1528
  article-title: Evaluation of [(1)(2)(3)I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 74
  start-page: 3805
  year: 1977
  end-page: 3809
  article-title: Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
  publication-title: Proc Natl Acad Sci U S A
– volume: 43
  start-page: 493
  year: 2017
  end-page: 496
  article-title: Microglia activation and schizophrenia: lessons from the effects of minocycline on postnatal neurogenesis, neuronal survival and synaptic pruning
  publication-title: Schizophr Bull
– volume: 24
  start-page: 623
  year: 2014
  end-page: 630
  article-title: Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!
  publication-title: Brain Pathol
– volume: 100
  start-page: 2347
  year: 2011
  end-page: 2355
  article-title: Modeling the light- and redox-dependent interaction of PpsR/AppA in
  publication-title: Biophys J
– volume: 39
  start-page: 1467
  year: 2012
  end-page: 1477
  article-title: Preclinical evaluation and quantification of [(1)(8)F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 24
  start-page: 620
  year: 2014
  end-page: 622
  article-title: Neuroinflammation: no rose by any other name
  publication-title: Brain Pathol
– volume: 32
  start-page: 1
  year: 2012
  end-page: 5
  article-title: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
  publication-title: J Cereb Blood Flow Metab
– volume: 58
  start-page: 320
  year: 2017
  end-page: 325
  article-title: 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain
  publication-title: J Nucl Med
– volume: 5
  start-page: 1005
  year: 1994
  end-page: 1014
  article-title: Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth
  publication-title: Cell Growth Differ
– volume: 35
  start-page: 157
  year: 1989
  end-page: 163
  article-title: Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control
  publication-title: Mol Pharmacol
– volume: 123
  start-page: 2321
  year: 2000
  end-page: 2337
  article-title: The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity
  publication-title: Brain
– volume: 25
  start-page: 842
  year: 2005
  end-page: 851
  article-title: Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies
  publication-title: J Cereb Blood Flow Metab
– volume: 43
  start-page: 2201
  year: 2016
  end-page: 2210
  article-title: Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 65
  start-page: 93
  year: 1990
  end-page: 97
  article-title: Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man
  publication-title: Cancer
– volume: 102
  start-page: 2118
  year: 2007
  end-page: 2131
  article-title: A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation
  publication-title: J Neurochem
– volume: 55
  start-page: 1966
  year: 2014
  end-page: 1972
  article-title: In vivo quantification of cerebral translocator protein binding in humans using 6-chloro-2-(4′-123I-iodophenyl)-3-(N,N-diethyl)-imidazo[1,2-a]pyridine-3-acetamid e SPECT
  publication-title: J Nucl Med
– volume: 94
  start-page: 5101
  year: 1997
  end-page: 5106
  article-title: A mammalian mitochondrial drug receptor functions as a bacterial “oxygen” sensor
  publication-title: Proc Natl Acad Sci USA
– volume: 43
  start-page: 173
  year: 2016
  end-page: 183
  article-title: Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 139
  start-page: 4991
  year: 1998
  end-page: 4997
  article-title: Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern
  publication-title: Endocrinology
– volume: 40
  start-page: 921
  year: 2013
  end-page: 931
  article-title: In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 31
  start-page: 1807
  year: 2011
  end-page: 1816
  article-title: Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography
  publication-title: J Cereb Blood Flow Metab
– volume: 294
  start-page: 161
  year: 1998
  end-page: 168
  article-title: Evidence for a diazepam-binding inhibitor (DBI) benzodiazepine receptor-like mechanism in ecdysteroidogenesis by the insect prothoracic gland
  publication-title: Cell Tissue Res
– volume: 30
  start-page: 1608
  year: 2010
  end-page: 1618
  article-title: Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation
  publication-title: J Cereb Blood Flow Metab
– volume: 53
  start-page: 2199
  year: 1999
  end-page: 2203
  article-title: [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis
  publication-title: Neurology
– volume: 37
  start-page: 2679
  year: 2017
  end-page: 2690
  article-title: Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans
  publication-title: J Cereb Blood Flow Metab
– volume: 241
  start-page: 426
  year: 1998
  end-page: 434
  article-title: PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection
  publication-title: Exp Cell Res
– volume: 49
  start-page: 2924
  year: 2010
  end-page: 2932
  article-title: Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker
  publication-title: Neuroimage
– volume: 59
  start-page: 831
  year: 1999
  end-page: 842
  article-title: Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol
  publication-title: Cancer Res
– volume: 62
  start-page: 21
  year: 1997
  end-page: 28
  article-title: Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis
  publication-title: Steroids
– volume: 16
  start-page: 436
  year: 2017
  end-page: 447
  article-title: Functional gains in energy and cell metabolism after TSPO gene insertion
  publication-title: Cell Cycle
– volume: 22
  start-page: 1308
  year: 2012
  end-page: 1313
  article-title: [(1)(8)F]GE-180: a novel fluorine-18 labelled PET tracer for imaging translocator protein 18 kDa (TSPO)
  publication-title: Bioorg Med Chem Lett
– volume: 44
  start-page: 296
  year: 2017
  end-page: 307
  article-title: Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 736
  start-page: 61
  year: 1999
  end-page: 66
  article-title: High-performance liquid chromatographic determination of [11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide in mouse plasma and tissue and in human plasma
  publication-title: J Chromatogr B Biomed Sci Appl
– volume: 86
  start-page: 4897
  year: 1989
  end-page: 4901
  article-title: Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor
  publication-title: Proc Natl Acad Sci U S A
– volume: 15
  start-page: 753
  year: 2010
  end-page: 768
  article-title: Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein
  publication-title: Apoptosis
– volume: 71
  start-page: 173
  year: 1981
  end-page: 175
  article-title: Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex
  publication-title: Eur J Pharmacol
– volume: 5
  start-page: 963
  year: 2014
  end-page: 971
  article-title: Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971
  publication-title: ACS Chem Neurosci
– volume: 289
  start-page: 13769
  year: 2014
  end-page: 13781
  article-title: Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18 kDa (TSPO))
  publication-title: J Biol Chem
– volume: 9
  start-page: 393
  year: 2009
  end-page: 407
  article-title: Autoimmune T cell responses in the central nervous system
  publication-title: Nat Rev Immunol
– volume: 173
  start-page: 536
  year: 2016
  end-page: 537
  article-title: Comment on analyses and conclusions of “microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study
  publication-title: Am J Psychiatry
– volume: 51
  start-page: 1283
  year: 1996
  end-page: 1292
  article-title: Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver
  publication-title: Biochem Pharmacol
– volume: 24
  start-page: 591
  year: 2005
  end-page: 595
  article-title: Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study
  publication-title: NeuroImage
– volume: 42
  start-page: 438
  year: 2015
  end-page: 446
  article-title: Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects
  publication-title: Eur J Nucl Med Mol Imaging
– volume: 11
  start-page: 346
  year: 2005
  end-page: 355
  article-title: Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS
  publication-title: J Neurovirol
– volume: 6
  start-page: e777
  year: 2016
  article-title: In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma
  publication-title: Transl Psychiatry
– volume: 33
  start-page: 131
  year: 2013
  end-page: 138
  article-title: The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [(1)(1)C]PBR28 PET study
  publication-title: Brain Behav Immun
– volume: 11
  start-page: e0167307
  year: 2016
  article-title: Global deletion of TSPO does not affect the viability and gene expression profile
  publication-title: PLoS One
– volume: 50
  start-page: 1276
  year: 2009
  end-page: 1282
  article-title: Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans
  publication-title: J Nucl Med
– volume: 371
  start-page: 197
  year: 1999
  end-page: 204
  article-title: Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors
  publication-title: Eur J Pharmacol
– volume: 264
  start-page: 20415
  year: 1989
  end-page: 20421
  article-title: Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor
  publication-title: J Biol Chem
– volume: 118
  start-page: 1
  year: 2008
  end-page: 17
  article-title: Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair
  publication-title: Pharmacol Ther
– volume: 51
  start-page: 629
  year: 1999
  ident: bibr46-0271678X17748786
  publication-title: Pharmacol Rev
  doi: 10.1016/S0031-6997(24)01424-8
– ident: bibr72-0271678X17748786
  doi: 10.1210/en.2015-1795
– ident: bibr105-0271678X17748786
  doi: 10.1038/jcbfm.2012.59
– ident: bibr136-0271678X17748786
  doi: 10.1016/j.bmcl.2011.12.084
– ident: bibr57-0271678X17748786
  doi: 10.1126/science.1248725
– ident: bibr67-0271678X17748786
  doi: 10.1073/pnas.81.3.753
– ident: bibr11-0271678X17748786
  doi: 10.1073/pnas.1511003112
– ident: bibr148-0271678X17748786
  doi: 10.1038/jcbfm.2014.261
– ident: bibr54-0271678X17748786
  doi: 10.1126/science.1260590
– ident: bibr108-0271678X17748786
  doi: 10.1038/jcbfm.1993.6
– ident: bibr74-0271678X17748786
  doi: 10.1016/S0304-3835(00)00451-1
– ident: bibr98-0271678X17748786
  doi: 10.1080/13550280500187351
– ident: bibr8-0271678X17748786
  doi: 10.1023/A:1018567510105
– ident: bibr21-0271678X17748786
  doi: 10.1001/jamaneurol.2016.3764
– ident: bibr61-0271678X17748786
  doi: 10.1074/jbc.M114.578286
– ident: bibr142-0271678X17748786
  doi: 10.1177/0271678X16646788
– ident: bibr12-0271678X17748786
  doi: 10.1523/JNEUROSCI.1487-12.2012
– ident: bibr6-0271678X17748786
  doi: 10.1038/nri2550
– ident: bibr26-0271678X17748786
– ident: bibr135-0271678X17748786
  doi: 10.1124/dmd.112.046342
– ident: bibr45-0271678X17748786
  doi: 10.1073/pnas.94.10.5101
– ident: bibr53-0271678X17748786
  doi: 10.1093/pcp/pch088
– ident: bibr80-0271678X17748786
  doi: 10.1016/j.pharmthera.2007.12.004
– ident: bibr81-0271678X17748786
  doi: 10.1016/j.bbi.2016.01.019
– ident: bibr20-0271678X17748786
  doi: 10.1093/brain/124.10.2014
– ident: bibr104-0271678X17748786
  doi: 10.1212/01.WNL.0000078192.95645.E6
– ident: bibr15-0271678X17748786
  doi: 10.1093/brain/123.11.2321
– volume: 34
  start-page: 272
  year: 1988
  ident: bibr56-0271678X17748786
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(25)09743-3
– ident: bibr59-0271678X17748786
  doi: 10.1210/en.2013-1556
– ident: bibr151-0271678X17748786
  doi: 10.1016/S0014-2999(99)00118-1
– ident: bibr111-0271678X17748786
  doi: 10.2967/jnumed.117.195396
– ident: bibr133-0271678X17748786
  doi: 10.1007/s00259-012-2163-3
– ident: bibr141-0271678X17748786
  doi: 10.3389/fnagi.2017.00008
– ident: bibr71-0271678X17748786
  doi: 10.1074/jbc.M115.686360
– ident: bibr145-0271678X17748786
  doi: 10.1007/s00259-014-2955-8
– ident: bibr114-0271678X17748786
  doi: 10.1038/jcbfm.2011.147
– ident: bibr95-0271678X17748786
  doi: 10.2967/jnumed.116.178335
– volume: 12
  start-page: 369
  year: 2012
  ident: bibr51-0271678X17748786
  publication-title: Curr Mol Med
– ident: bibr27-0271678X17748786
  doi: 10.1176/appi.ajp.2016.15111417
– ident: bibr122-0271678X17748786
  doi: 10.1124/jpet.116.238568
– ident: bibr147-0271678X17748786
  doi: 10.1038/tp.2016.40
– volume: 265
  start-page: 15015
  year: 1990
  ident: bibr40-0271678X17748786
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)77217-7
– ident: bibr63-0271678X17748786
  doi: 10.1210/endo.139.12.6390
– ident: bibr73-0271678X17748786
  doi: 10.1016/0006-2952(96)00034-2
– ident: bibr129-0271678X17748786
  doi: 10.1007/s00259-015-3149-8
– volume: 12
  start-page: 494
  year: 2012
  ident: bibr66-0271678X17748786
  publication-title: Curr Mol Med
– ident: bibr37-0271678X17748786
  doi: 10.1016/0014-2999(81)90405-2
– ident: bibr126-0271678X17748786
  doi: 10.2967/jnumed.116.178996
– ident: bibr134-0271678X17748786
  doi: 10.2967/jnumed.110.077040
– ident: bibr44-0271678X17748786
  doi: 10.1016/j.bpj.2011.04.017
– ident: bibr152-0271678X17748786
  doi: 10.1016/S0960-894X(02)00886-7
– ident: bibr38-0271678X17748786
  doi: 10.1016/0024-3205(83)90062-0
– volume: 35
  start-page: 157
  year: 1989
  ident: bibr43-0271678X17748786
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(25)10080-1
– ident: bibr36-0271678X17748786
  doi: 10.1073/pnas.74.9.3805
– ident: bibr146-0271678X17748786
  doi: 10.2967/jnumed.109.062265
– ident: bibr87-0271678X17748786
  doi: 10.1097/NEN.0b013e318188b204
– ident: bibr84-0271678X17748786
  doi: 10.1002/1097-0142(19900101)65:1<93::AID-CNCR2820650120>3.0.CO;2-1
– ident: bibr18-0271678X17748786
  doi: 10.1212/WNL.55.7.1052
– ident: bibr139-0271678X17748786
  doi: 10.1007/s00259-016-3444-z
– ident: bibr119-0271678X17748786
  doi: 10.1016/j.nucmedbio.2007.12.009
– ident: bibr19-0271678X17748786
  doi: 10.1001/jamaneurol.2015.0941
– ident: bibr86-0271678X17748786
  doi: 10.1023/A:1005933226966
– ident: bibr96-0271678X17748786
  doi: 10.1016/j.nucmedbio.2014.11.003
– ident: bibr100-0271678X17748786
  doi: 10.1038/sj.jcbfm.9600340
– ident: bibr150-0271678X17748786
  doi: 10.1016/S0378-4347(99)00439-9
– ident: bibr125-0271678X17748786
  doi: 10.1021/cn500138n
– ident: bibr23-0271678X17748786
  doi: 10.1016/j.neubiorev.2010.10.001
– ident: bibr28-0271678X17748786
  doi: 10.1016/S0928-4257(02)00018-9
– ident: bibr9-0271678X17748786
  doi: 10.1038/ncomms6452
– ident: bibr110-0271678X17748786
  doi: 10.1038/jcbfm.2014.55
– ident: bibr120-0271678X17748786
  doi: 10.1016/j.neuroimage.2009.11.056
– ident: bibr5-0271678X17748786
  doi: 10.1007/s10048-014-0409-x
– ident: bibr14-0271678X17748786
  doi: 10.1016/S1474-4422(15)70016-5
– ident: bibr117-0271678X17748786
  doi: 10.1093/ijnp/pyw077
– ident: bibr156-0271678X17748786
  doi: 10.1007/s00259-007-0645-5
– ident: bibr124-0271678X17748786
  doi: 10.1177/0271678X17699223
– ident: bibr69-0271678X17748786
  doi: 10.1080/15384101.2017.1281477
– volume: 266
  start-page: 14082
  year: 1991
  ident: bibr48-0271678X17748786
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)92812-7
– ident: bibr79-0271678X17748786
  doi: 10.1016/0024-3205(93)90293-C
– ident: bibr22-0271678X17748786
  doi: 10.1001/jamapsychiatry.2014.2427
– volume: 53
  start-page: 501
  year: 2010
  ident: bibr90-0271678X17748786
  publication-title: J Labelled Compd Radiopharm
  doi: 10.1002/jlcr.1752
– ident: bibr13-0271678X17748786
  doi: 10.1016/S0140-6736(01)05625-2
– ident: bibr16-0271678X17748786
  doi: 10.1016/j.neuroimage.2004.09.034
– ident: bibr3-0271678X17748786
  doi: 10.1111/bpa.12196
– ident: bibr121-0271678X17748786
  doi: 10.1002/syn.20027
– ident: bibr78-0271678X17748786
  doi: 10.1007/s00259-011-1784-2
– ident: bibr70-0271678X17748786
  doi: 10.1089/dna.2016.3385
– ident: bibr130-0271678X17748786
  doi: 10.1007/s00259-016-3517-z
– ident: bibr140-0271678X17748786
  doi: 10.1007/s00259-017-3799-9
– ident: bibr157-0271678X17748786
  doi: 10.2967/jnumed.114.143727
– ident: bibr88-0271678X17748786
  doi: 10.1034/j.1600-0404.2001.103005309.x
– ident: bibr144-0271678X17748786
  doi: 10.1038/jcbfm.2014.46
– ident: bibr52-0271678X17748786
  doi: 10.1007/s004410051166
– ident: bibr2-0271678X17748786
  doi: 10.1111/bpa.12192
– ident: bibr25-0271678X17748786
  doi: 10.1176/appi.ajp.2016.15111417r
– ident: bibr97-0271678X17748786
  doi: 10.2967/jnumed.116.183202
– ident: bibr83-0271678X17748786
  doi: 10.1038/jcbfm.2010.63
– ident: bibr153-0271678X17748786
  doi: 10.1016/j.bbi.2013.06.010
– ident: bibr10-0271678X17748786
  doi: 10.1111/j.1460-9568.2006.04975.x
– ident: bibr106-0271678X17748786
  doi: 10.2967/jnumed.115.156083
– ident: bibr149-0271678X17748786
  doi: 10.1111/j.1471-4159.2007.04690.x
– ident: bibr143-0271678X17748786
  doi: 10.1038/sj.jcbfm.9600325
– ident: bibr113-0271678X17748786
  doi: 10.2967/jnumed.110.079459
– ident: bibr34-0271678X17748786
  doi: 10.2967/jnumed.107.044842
– ident: bibr32-0271678X17748786
  doi: 10.1002/ana.410260611
– volume: 48
  start-page: 158
  year: 2007
  ident: bibr103-0271678X17748786
  publication-title: J Nucl Med
– ident: bibr47-0271678X17748786
  doi: 10.1016/0361-9230(87)90158-4
– ident: bibr68-0271678X17748786
  doi: 10.1006/excr.1998.4084
– ident: bibr127-0271678X17748786
  doi: 10.2967/jnumed.113.121020
– ident: bibr4-0271678X17748786
  doi: 10.1111/bpa.12195
– ident: bibr41-0271678X17748786
  doi: 10.1073/pnas.86.24.9813
– ident: bibr116-0271678X17748786
  doi: 10.1038/jcbfm.2012.46
– ident: bibr64-0271678X17748786
  doi: 10.1007/s10495-010-0460-5
– ident: bibr118-0271678X17748786
  doi: 10.1007/s00259-013-2359-1
– ident: bibr50-0271678X17748786
  doi: 10.1111/j.1471-4159.1989.tb07361.x
– ident: bibr89-0271678X17748786
  doi: 10.1038/jcbfm.2014.63
– ident: bibr7-0271678X17748786
  doi: 10.1038/mp.2016.248
– ident: bibr91-0271678X17748786
  doi: 10.1111/ejn.12946
– ident: bibr29-0271678X17748786
  doi: 10.1097/00001756-200111160-00012
– ident: bibr102-0271678X17748786
  doi: 10.1038/mp.2016.180
– ident: bibr35-0271678X17748786
  doi: 10.2967/jnumed.114.149443
– ident: bibr85-0271678X17748786
  doi: 10.1002/syn.20257
– ident: bibr92-0271678X17748786
  doi: 10.1111/jnc.13370
– ident: bibr82-0271678X17748786
  doi: 10.1177/0271678X17710182
– ident: bibr115-0271678X17748786
  doi: 10.1038/jcbfm.2012.131
– ident: bibr39-0271678X17748786
  doi: 10.1073/pnas.86.13.4897
– ident: bibr93-0271678X17748786
  doi: 10.1002/syn.20394
– ident: bibr137-0271678X17748786
  doi: 10.1016/S0969-8051(02)00410-9
– ident: bibr112-0271678X17748786
  doi: 10.1016/j.neuroimage.2007.11.011
– ident: bibr109-0271678X17748786
  doi: 10.1038/sj.jcbfm.9600092
– ident: bibr76-0271678X17748786
  doi: 10.1046/j.1471-4159.2000.0741694.x
– ident: bibr94-0271678X17748786
  doi: 10.1186/s13550-017-0304-1
– volume: 43
  start-page: 493
  year: 2017
  ident: bibr30-0271678X17748786
  publication-title: Schizophr Bull
– ident: bibr55-0271678X17748786
  doi: 10.1126/science.aaa1534
– ident: bibr131-0271678X17748786
  doi: 10.1038/jcbfm.2011.55
– ident: bibr42-0271678X17748786
  doi: 10.1016/j.tips.2006.06.005
– ident: bibr154-0271678X17748786
  doi: 10.1021/acs.jmedchem.5b00932
– ident: bibr1-0271678X17748786
  doi: 10.1111/bpa.12198
– ident: bibr17-0271678X17748786
  doi: 10.1016/j.bbadis.2015.11.011
– volume: 264
  start-page: 20415
  year: 1989
  ident: bibr49-0271678X17748786
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)47078-6
– volume: 59
  start-page: 831
  year: 1999
  ident: bibr75-0271678X17748786
  publication-title: Cancer Res
– ident: bibr99-0271678X17748786
  doi: 10.1038/jcbfm.2014.202
– ident: bibr132-0271678X17748786
  doi: 10.2967/jnumed.108.060186
– ident: bibr107-0271678X17748786
  doi: 10.1007/s00259-005-0052-8
– ident: bibr58-0271678X17748786
  doi: 10.1016/S0039-128X(96)00154-7
– ident: bibr123-0271678X17748786
  doi: 10.1002/syn.21970
– ident: bibr128-0271678X17748786
  doi: 10.1186/2191-219X-2-15
– volume: 11
  start-page: e0167307
  year: 2016
  ident: bibr62-0271678X17748786
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0167307
– ident: bibr31-0271678X17748786
  doi: 10.1016/j.redox.2016.08.002
– ident: bibr33-0271678X17748786
  doi: 10.1212/WNL.53.9.2199
– ident: bibr24-0271678X17748786
  doi: 10.5694/j.1326-5377.2009.tb02371.x
– volume: 12
  start-page: 398
  year: 2012
  ident: bibr65-0271678X17748786
  publication-title: Curr Mol Med
– ident: bibr101-0271678X17748786
  doi: 10.1016/j.neuroimage.2006.11.003
– ident: bibr60-0271678X17748786
  doi: 10.1074/jbc.M114.549634
– ident: bibr138-0271678X17748786
  doi: 10.2967/jnumed.115.169078
– volume: 5
  start-page: 1005
  year: 1994
  ident: bibr77-0271678X17748786
  publication-title: Cell Growth Differ
– ident: bibr155-0271678X17748786
  doi: 10.1016/j.nucmedbio.2010.07.008
SSID ssj0008355
Score 2.532254
SecondaryResourceType review_article
Snippet The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of...
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-(...
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ C]-(...
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(...
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-(...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 204
SubjectTerms Biomarkers - analysis
Humans
Inflammation - diagnosis
Inflammation - diagnostic imaging
Inflammation - pathology
Microglia - pathology
Nervous System Diseases - diagnosis
Nervous System Diseases - diagnostic imaging
Nervous System Diseases - metabolism
Positron-Emission Tomography
Review
Tomography, Emission-Computed, Single-Photon
Title Sifting through the surfeit of neuroinflammation tracers
URI https://journals.sagepub.com/doi/full/10.1177/0271678X17748786
https://www.ncbi.nlm.nih.gov/pubmed/29256293
https://www.proquest.com/docview/1978732504
https://pubmed.ncbi.nlm.nih.gov/PMC5951023
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6F8gAvCFoOc8lIqBJCpt7Dxz42EahCKlSilfJm2eu1GhLbUeI8tL-DH8zsYcc5QNAXJ_E6nsTzeXbW880MQu-FWnPEWHiZxKnHYrCDXPrSk0ywUBBWsFjlO59_C8-u2NdxMB4MfvVYS6sm-yRu9-aV3EWrsA_0qrJk_0Oz3UlhB7wH_cIWNAzbf9Lxj0lh-jzYZjvKiVyuFoWc6Pi-rlUJckDpJkFRNYQQlvK-xyOFIRVGnhk2-8diVhu6cCkbgMqsLTaoCdVlaZuh9KmFQxWyMRgY_qwXHe4u0mZqiNzfy2na0YGH4LBOl3NphvoEfvsYAsctc3kj_rX_SSOJsAdz4thMOdbOBtyLfJNm2RpiGvcAR_pW1XQothM0MUnXu7ZfR5-VNCUMPsFazJTZ7kFhXmosEA6uHjG9GbfqbV-cjwLldhJ6D90nsPjQKeTjNXEIfFZNjG3_1jr4fbItXJWatpI2_Z6dxcwuJ7dHLNS-zuVj9MhCwj01iHuCBrI6REenVdrU5Y177GrasI7HHKIHo7Zl4BGKLSBdC0h4la4FpFsX7g4gXQvIp-jqy-fL0ZlnW3N4IvD9xhNFlgVZHqbg7gpGc86KuBBqtR2ENA95livvr6A0ZzCD8SiVWNBQkjznnGDJ6TN0UNWVfIFcQEIYcwxuPSNgHtIsCkWY-lTEOWNSBg46aS9cImzdetU-ZZbgtlT91lV30IfuG3NTs-Uvx75rdZHAxVLRsrSS9WqZYA5zGVUV_hz03OimO1urVAdFG1rrDlBF2zdHqsm1Lt5useWgY6XfxFqT5R9_4Ms7i3iFHq5v1NfooFms5BvwoJvsrQb0b7iAw80
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sifting+through+the+surfeit+of+neuroinflammation+tracers&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Cumming%2C+Paul&rft.au=Burgher%2C+Bjorn&rft.au=Patkar%2C+Omkar&rft.au=Breakspear%2C+Michael&rft.date=2018-02-01&rft.pub=SAGE+Publications&rft.issn=0271-678X&rft.eissn=1559-7016&rft.volume=38&rft.issue=2&rft.spage=204&rft.epage=224&rft_id=info:doi/10.1177%2F0271678X17748786&rft_id=info%3Apmid%2F29256293&rft.externalDocID=PMC5951023
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon